VIE/ZBH (VIE/ZBH)

Vienna Stock Exchange: VIE/ZBH · EUR

€85.5

-1.52 (-1.7%)· Recorded snapshot

Market cap	16.4B
Revenue (ttm)	7.4B
Net income (ttm)	706.1M
EPS (ttm)	€3.68
P/E (trailing)	23.2x
P/E (forward)	11.2x
Dividend	€0.84 (0.98%)
Volume	244

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.4B
Net income (ttm): 706.1M
EPS (ttm): €3.68
P/E (trailing): 23.2x
P/E (forward): 11.2x
Market cap: 16.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/E11.2

P25 n/aP50 n/aP75 n/a

Trailing P/E23.2

P25 n/aP50 n/aP75 n/a

ROE6.4

P25 n/aP50 n/aP75 n/a

ROIC6.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/ZBH indicators

Market & fundamental data

Available fields

247

Groups with data

Currency

USD

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-11-04
Employees	17,000
Employees change	-1,000
Employees growth	-5.56%
Enterprise value	EUR 22.8B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1927
Industry	Medical Devices
Is primary listing	No
ISIN number	US98956P1021
Last earnings date	2026-08-05
Last refreshed	2026-10-30
Market cap	EUR 16.4B
Next earnings date	2026-11-04
Price	EUR 85.54
Price currency	EUR
Sector	Healthcare
SIC code	3842
Stock price date	2026-10-30
Symbol	vie/ZBH
Website	https://www.zimmerbiomet.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	62.14x
Average P/E ratio (3Y)	25.69x
Average P/E ratio (5Y)	47.28x
Earnings yield	4.3%
EV/Earnings	32.65x
EV/EBIT	18.17x
EV/EBITDA	9.94x
EV/FCF	21.95x
EV/Sales	3.02x
FCF / EV yield	4.56%
FCF yield	6.31%
Forward P/E	11.18x
Graham number	69.29457
Graham upside	-20.41%
Lynch fair value	EUR 18.46
Lynch upside	-78.8%
P/(FCF - SBC) ratio	17.27x
P/(OCF - SBC) ratio	11.56x
P/B ratio	1.51x
P/E ratio	23.25x
P/FCF ratio	15.85x
P/OCF ratio	10.91x
P/S ratio	2.24x
Price/EBITDA ratio	7.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.65%
EBITDA margin	29.68%
Effective tax rate	13.56%
FCF margin	13.81%
Gross margin	69.52%
Operating margin	16.65%
Pretax margin	10.97%
Profit margin	9.48%
Profit per employee	EUR 41,536
Profitable quarters	14
Profitable years	5
Revenue per employee	EUR 438,103
ROA	3.88%
ROA (5Y)	3.96%
ROCE	7.16%
ROE	6.41%
ROE (5Y)	5.43%
ROIC	6.19%
ROIC (5Y)	6.45%
SBC / revenue	1.15%
Tax / revenue	1.49%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	0.17%
EPS growth (Q)	33.77%
EPS growth (QoQ)	-15.57%
EPS growth 10Y	14.16%
EPS growth 3Y	19.72%
EPS growth 5Y	-1.28%
EPS growth quarters	2
EPS growth years	0
FCF growth	-3.14%
FCF growth (Q)	24.48%
FCF growth (QoQ)	25.34%
FCF growth 3Y	14.96%
FCF growth 5Y	1.17%
Gross profit growth	6.05%
Gross profit growth (Q)	3.8%
Gross profit growth 3Y	4.66%
Gross profit growth 5Y	2.29%
Net income growth	-2.04%
Net income growth (Q)	29.78%
Net income growth (QoQ)	-16.72%
Net income growth 3Y	16.85%
Net income growth 5Y	-2.51%
Net income growth quarters	2
Net income growth years	0
OCF growth	4.83%
OCF growth (Q)	18.4%
OCF growth (QoQ)	24.6%
OCF growth 10Y	3.69%
OCF growth 3Y	8.88%
OCF growth 5Y	2.96%
Operating income growth	-8.28%
Operating income growth (Q)	-3.22%
Operating income growth 3Y	0.13%
Operating income growth 5Y	1.82%
Revenue growth	8.62%
Revenue growth (Q)	4.8%
Revenue growth (QoQ)	4.33%
Revenue growth 10Y	1.22%
Revenue growth 3Y	5.75%
Revenue growth 5Y	2.89%
Revenue growth quarters	15
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -475.5M
Depreciation and amortization	EUR 990.8M
EBIT	EUR 1.2B
EBITDA	EUR 2.2B
EPS	EUR 3.68
Financing cash flow	EUR -922.1M
Free cash flow	EUR 1.1B
Free cash flow minus SBC	EUR 964.5M
Gross profit	EUR 5.2B
Income taxes	EUR 110.8M
Investing cash flow	EUR -731M
Net borrowing	EUR -41.1M
Net cash flow	EUR -128.6M
Net income	EUR 706.1M
Operating cash flow minus SBC	EUR 1.4B
Operating income	EUR 1.2B
Revenue	EUR 7.4B
Stock-based compensation	EUR 86M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.51
Book value per share	EUR 57.97
Debt / EBITDA	2.94
Debt / equity	0.6
Debt / FCF	6.33
Goodwill	EUR 8.9B
Interest coverage	4.9
Long-term assets	EUR 15.4B
Long-term liabilities	EUR 6.2B
Net cash (debt)	EUR -6.2B
Net cash / market cap	-37.52%
Net debt / EBITDA	2.83
Net debt / equity	0.56
Net debt / FCF	5.95
Piotroski F-Score	6
Property, plant and equipment	EUR 2B
Shareholders' equity	EUR 11.1B
Tangible book value	EUR -1.5B
Tangible book value per share	EUR -8.07
Total assets	EUR 20B
Total cash	EUR 406.6M
Total debt	EUR 6.7B
Total liabilities	EUR 8.9B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.37
Current assets	EUR 4.6B
Current liabilities	EUR 2.7B
Current ratio	1.69
Inventory turnover	1.1
Net working capital	EUR 2.5B
Quick ratio	0.74
Working capital	EUR 1.8B
Working capital turnover	3.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.95%
Dividend growth	-3.02%
Dividend growth (3Y)	-2.27%
Dividend growth (5Y)	0.73%
Dividend growth years	0
Dividend payment date	2026-10-30
Dividend payment years	7
Dividend payout frequency	Quarterly
Dividend per share	EUR 0.84
Dividend yield	0.98%
Ex-dividend date	2026-09-30
Last dividend	EUR 0.21
Payout ratio	23.35%
Shareholder yield	2.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 79.49
1D price change	-1.75%
1M price change	7.06%
1M total return	7.34%
1W price change	-1.99%
1W total return	-1.99%
1Y price change	-0.79%
1Y return CAGR	0.29%
1Y total return	0.29%
20-day SMA	EUR 83.25
200-day SMA	EUR 79.26
3M price change	1.04%
3M total return	1.31%
3Y price change	-12.39%
3Y return CAGR	-3.4%
3Y total return	-9.85%
50-day SMA	EUR 83.22
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 90.30
52-week high date	2025-11-05
52-week low	EUR 67.66
52-week low date	2026-05-12
5Y price change	-30.17%
5Y return CAGR	-5.53%
5Y total return	-24.73%
6M price change	24.15%
6M total return	24.82%
All-time high	EUR 138.40
All-time high date	2021-07-30
All-time low	EUR 67.66
All-time low date	2026-05-12
Average true range (ATR)	EUR 1.66
Average volume	27.6
Change from 52-week high	-5.27%
Change from 52-week low	26.43%
Change from all-time high	-38.19%
Change from all-time low	26.43%
Change from open	2.17%
Day's gap	-3.84%
Dollar volume	EUR 20,872
High price	EUR 86.74
Low price	EUR 83.72
Monthly RSI	48.85
Open price	EUR 83.72
Position in 52-week range	60.26%
Previous close	EUR 87.06
Price vs 150-day SMA	7.62%
Price vs 20-day SMA	2.75%
Price vs 200-day SMA	7.93%
Price vs 50-day SMA	2.79%
Relative volume	15.84
RSI	55.53
Sharpe ratio	-0.01
Sharpe ratio (3Y)	-0.16
Sharpe ratio (5Y)	-0.24
Sortino ratio	0.14
Sortino ratio (3Y)	-0.02
Sortino ratio (5Y)	-0.13
Volume	244
Weekly RSI	55.61
YTD price change	11.44%
YTD total return	12.35%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	190.1M
Shares change (QoQ)	-1.53%
Shares change (YoY)	-1.95%
Shares held by insiders	0.18%
Shares held by institutions	106.08%
Short ratio	3.8 days

Deeper analysis on VIE/ZBH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/ZBH report

Is a complete VIE/ZBH research report available?

No complete published report is available for vie/ZBH (VIE/ZBH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/ZBH (VIE/ZBH)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/ZBH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/ZBH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/ZBH

Frequently asked questions